With more research laboratories entering the market and demand for commercial assays growing, researchers often look to obtain miRNA tools through routes other than commercial miRNA microarray vendors. For instance, researchers can produce in-house miRNA microarrays or their own miRNA knockdown and up-regulation tools. This is a major underlying limitation to the market, which is also challenged by potential pricing pressures.
Nevertheless, the impact of these restraints will decline as miRNA functional analysis matures and vendors enhance tools. Eventually, commoditisation will lead to a drop in costs and nullify any cost and quality benefits of in-house production.
"To sustain product value until then, market participants must continue to offer technology improvements and differentiated features, and strategically compete without making deep pricing cuts that may irreversibly damage market potential," suggested Ravishankar. "Providing complete workflow solutions and discounts when a customer purchases products along with several different portfolios will simplify purchasing and attract new customers."
If you are interested in more information on this research, please send an email to Anna Zanchi, Corporate Communications, at email@example.com
Global Analysis of MicroRNA Tools and Services Market is part of the Life Sciences Growth Partnership Service program. Frost & Sullivan's related research services include: Strategic Analysis of the U.S. Next-Generation Sequencing Services Market, European PCR Reagent Market for Research Applications and C
|SOURCE Frost & Sullivan|
Copyright©2012 PR Newswire.
All rights reserved